May15, 2018

May 15th, 2018|Homepage News, News|

May 16, 2018: On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib.  

Collaboration marks first therapy submission for the treatment of Progeria. If approved, children may access drug by prescription instead of clinical trial. Click here for more details.
Apr24, 2018

April 24, 2018: Global Study Published in JAMA Finds Treatment with Lonafarnib Extends Survival in Children with Progeria!

April 24th, 2018|Homepage News, News|

A new study published in The Journal of the American Medical Association (JAMA) brings new hope and optimism to the Progeria community. Click here for more details.
Feb2, 2018

September 20 – 22, 2018 in Cambridge, MA: Join us for PRF’s 9th International Scientific Workshop, “MANY PATHWAYS, ONE GOAL”, the world’s largest conference of its kind .

February 2nd, 2018|News|